oxylabs - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 10,999,383 | 4,494,118 | 9,012,580 | 16,740,687 | 37,788,775 | 44,875,318 | 80,941,075 | 139,500,685 |
| Profit before tax | 902,012 | -1,002,206 | 2,311,239 | 5,335,730 | 19,606,415 | 7,141,485 | 28,983,460 | 66,371,818 |
| Net profit | 735,995 | -876,381 | 1,946,960 | - | 18,258,932 | 6,633,236 | 26,934,463 | 62,683,295 |
| Equity | 149,308 | -774,610 | 1,150,102 | 5,305,542 | 17,864,461 | 7,040,837 | 29,475,039 | 63,567,899 |
| Liabilities | 4,136,489 | 3,466,871 | 1,430,695 | - | 5,283,544 | 7,697,579 | 8,591,332 | 13,784,648 |
| Non-current assets | 81,458 | 174,344 | 99,751 | 198,407 | 2,533,183 | 4,690,080 | 3,789,079 | 22,313,979 |
| Current assets | 4,248,128 | 2,481,837 | 2,808,450 | 7,294,964 | 20,614,822 | 10,048,336 | 34,277,292 | 55,038,568 |
| Total assets | 4,329,586 | 2,656,181 | 2,908,201 | 7,493,371 | 23,148,005 | 14,738,416 | 38,066,371 | 77,352,547 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,481,128 | 485,248 | 2,753,037 |
| Social insurance contributions | - | - | - | - | - | 2,323,735 | 2,787,198 | 3,338,337 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +54.7% | -59.1% | +100.5% | +85.7% | +125.7% | +18.8% | +80.4% | +72.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.0% | -33.0% | 66.9% | - | 78.9% | 45.0% | 70.8% | 81.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 492.9% | - | 169.3% | - | 102.2% | 94.2% | 91.4% | 98.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.7% | -19.5% | 21.6% | - | 48.3% | 14.8% | 33.3% | 44.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.2% | -22.3% | 25.6% | 31.9% | 51.9% | 15.9% | 35.8% | 47.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 27.7 | - | 1.2 | - | 0.3 | 1.1 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 177,171 | 164,922 | 415,965 | 816,619 | 1,042,449 | 212,428 | 355,524 | 543,862 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
oxylabs - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-24 | 0.55 |
| 2025-12-22 | 2025-12-22 | 0.14 |
oxylabs - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.